239 related articles for article (PubMed ID: 11095456)
1. Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. KIGS International Board. Kabi International Growth Study.
Ranke MB; Lindberg A; Chatelain P; Wilton P; Cutfield W; Albertsson-Wikland K; Price DA;
J Clin Endocrinol Metab; 2000 Nov; 85(11):4212-8. PubMed ID: 11095456
[TBL] [Abstract][Full Text] [Related]
2. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study.
Ranke MB; Lindberg A; Chatelain P; Wilton P; Cutfield W; Albertsson-Wikland K; Price DA
J Clin Endocrinol Metab; 1999 Apr; 84(4):1174-83. PubMed ID: 10199749
[TBL] [Abstract][Full Text] [Related]
3. Predicting the response to recombinant human growth hormone in Turner syndrome: KIGS models. KIGS International Board. Kabi International Growth Study.
Ranke MB; Lindberg A; Chatelain P; Wilton P; Cutfield W; Albertsson-Wikland K; Price DA
Acta Paediatr Suppl; 1999 Dec; 88(433):122-5. PubMed ID: 10626562
[TBL] [Abstract][Full Text] [Related]
4. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
[TBL] [Abstract][Full Text] [Related]
5. Accurate long-term prediction of height during the first four years of growth hormone treatment in prepubertal children with growth hormone deficiency or Turner Syndrome.
Ranke MB; Lindberg A; Brosz M; Kaspers S; Loftus J; Wollmann H; Kołtowska-Haggstrom M; Roelants M
Horm Res Paediatr; 2012; 78(1):8-17. PubMed ID: 22832697
[TBL] [Abstract][Full Text] [Related]
6. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
Binder G; Baur F; Schweizer R; Ranke MB
J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
[TBL] [Abstract][Full Text] [Related]
7. Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome.
Cacciari E; Mazzanti L
J Clin Endocrinol Metab; 1999 Dec; 84(12):4510-5. PubMed ID: 10599710
[TBL] [Abstract][Full Text] [Related]
8. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
Nilsson KO; Albertsson-Wikland K; Alm J; Aronson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson SA; Karlberg J; Kriström B; Marcus C; Moell C; Ritzen M; Tuvemo T; Wattsgård C; Westgren U; Westphal O; Aman J
J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
Cutfield WS; Lundgren F
Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
[TBL] [Abstract][Full Text] [Related]
10. Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age.
Stahnke N; Keller E; Landy H;
J Pediatr Endocrinol Metab; 2002 Feb; 15(2):129-38. PubMed ID: 11874177
[TBL] [Abstract][Full Text] [Related]
11. Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database).
Ranke MB; Lindberg A; Cowell CT; Wikland KA; Reiter EO; Wilton P; Price DA;
J Clin Endocrinol Metab; 2003 Jan; 88(1):125-31. PubMed ID: 12519840
[TBL] [Abstract][Full Text] [Related]
12. Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS.
Ranke MB; Lindberg A; Ferrández Longás A; Darendeliler F; Albertsson-Wikland K; Dunger D; Cutfield WS; Tauber M; Wilton P; Wollmann HA; Reiter EO;
Pediatr Res; 2007 Jan; 61(1):105-10. PubMed ID: 17211150
[TBL] [Abstract][Full Text] [Related]
13. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.
van Pareren YK; de Muinck Keizer-Schrama SM; Stijnen T; Sas TC; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Stokvis-Brantsma WH; Rouwé CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL
J Clin Endocrinol Metab; 2003 Mar; 88(3):1119-25. PubMed ID: 12629094
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.
Menke LA; Sas TC; de Muinck Keizer-Schrama SM; Zandwijken GR; de Ridder MA; Odink RJ; Jansen M; Delemarre-van de Waal HA; Stokvis-Brantsma WH; Waelkens JJ; Westerlaken C; Reeser HM; van Trotsenburg AS; Gevers EF; van Buuren S; Dejonckere PH; Hokken-Koelega AC; Otten BJ; Wit JM
J Clin Endocrinol Metab; 2010 Mar; 95(3):1151-60. PubMed ID: 20061421
[TBL] [Abstract][Full Text] [Related]
15. Adult height and pubertal growth in Turner syndrome after treatment with recombinant growth hormone.
Soriano-Guillen L; Coste J; Ecosse E; Léger J; Tauber M; Cabrol S; Nicolino M; Brauner R; Chaussain JL; Carel JC
J Clin Endocrinol Metab; 2005 Sep; 90(9):5197-204. PubMed ID: 15998771
[TBL] [Abstract][Full Text] [Related]
16. Growth response and final height in Turner syndrome after combination therapy of growth hormone and anabolic steroid.
Shu SG
Acta Paediatr Taiwan; 2000; 41(6):322-6. PubMed ID: 11198939
[TBL] [Abstract][Full Text] [Related]
17. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
[TBL] [Abstract][Full Text] [Related]
18. Observed and predicted total pubertal growth during treatment with growth hormone in adolescents with idiopathic growth hormone deficiency, Turner syndrome, short stature, born small for gestational age and idiopathic short stature: KIGS analysis and review.
Ranke MB; Lindberg A
Horm Res Paediatr; 2011; 75(6):423-32. PubMed ID: 21358173
[TBL] [Abstract][Full Text] [Related]
19. Observed and predicted growth responses in prepubertal children with growth disorders: guidance of growth hormone treatment by empirical variables.
Ranke MB; Lindberg A;
J Clin Endocrinol Metab; 2010 Mar; 95(3):1229-37. PubMed ID: 20097713
[TBL] [Abstract][Full Text] [Related]
20. Validation and calibration of the Kabi Pharmacia International Growth Study prediction model for children with idiopathic growth hormone deficiency.
de Ridder MA; Stijnen T; Hokken-Koelega AC
J Clin Endocrinol Metab; 2003 Mar; 88(3):1223-7. PubMed ID: 12629110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
